Trial intelligence / Profile preview

Rosuvastatin for vascular and joint outcomes in rheumatoid arthritis

2004-001909-10Phase 4Completed

Sponsor
University of Dundee
Start
Aug 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in rheumatoid arthritis (RA) and cardiac morbidity comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: Blood tests for vascular markers and inflammation. Started Aug 2005; status: completed.

02

Drugs

rosuvastatin
03

Conditions

rheumatoid arthritis (RA)cardiac morbidity

Beyond the preview

Go deeper on 2004-001909-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-001909-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call